MIcronized PROgesterone in Frozen Embryo Transfer Cycles
Recruiting
Phase 3
Interventional Study
Infertility
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Pivotal Trial
This treatment is in the last trial phase before FDA approval.
Prior Safety Data
This treatment has already been tested in at least one earlier human trial.
At a Glance
- Age
- 18 – 50
- Sex
- Female
- Trial phase
- Phase 3
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 1,020 (estimated)
- Sponsor
- Fundación Santiago Dexeus Font · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
This randomized trial was designed as non-inferiority trial aiming to compare ongoing pregnancy rates following LPS with 600 mg/day vs 800 mg/day vaginal VMP. All patients will undergo an artificial cycle frozen embryo transfer (AC-FET) with transdermal estradiol 6mg/day Patients undergoing an artificial cycle FET will start estrogen priming with transdermal estradiol 6mg/day (Estrogel®) on cycle …
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Endometrial preparation with hormone replacement therapy
* Age 18-43 years following an autologous IVF cycle (with or without preimplantation genetic testing for aneuploidy)
* Age \< 50 years following an egg donation cycle
* BMI \> 18 and \< 30 kg/m2
* blastocyst embryo trans…
Contacts